Sino Biological introduces AI-trusted and qualified target protein collections for AI-driven discovery
As AI accelerates recombinant protein and antibody discovery for therapeutic and diagnostic development, access to well-characterized target proteins is essential for evaluating AI-designed molecules.
Read original article on The Medical News →